Manufacturer record
Ipca Laboratory Ltd. Sejavta: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Ipca Laboratory Ltd. Sejavta were declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: INCO14030R, Pacimol MF 250 Suspension (exp Aug 2027). DTL Jabalpur (M.P.) (state lab) found it not of standard quality: Suspension does not dispose uniformaly on shaking. Listed in the July 2026 alert.
Records by type
2 records linked to Ipca Laboratory Ltd. Sejavta in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pacimol MF 250 Suspension | Batch INCO14030RMfg Sep 2024 · Exp Aug 2027 | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab | Jul 2026 |
| Pacimol MF 250 Suspension | Batch INCO14035RMfg Oct 2024 · Exp Sep 2027 | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab | Jul 2026 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.